Physician

Matthew J Dykhuizen, M.D.

According to 2025 Medicare claims, Matthew Dykhuizen, M.D. (NPI: 1609004308) practices ophthalmology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Kenton, KY. This provider's primary affiliated billing organization is TRI-STATE CENTERS FOR SIGHT, INC. (NPI: 1467520296; TIN: 311413395) and primary practice location at 41017-3931. Dykhuizen is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Dykhuizen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 504 traditional Medicare patients, billed 14,266 HCPCS/CPT codes, and received $1,250,553 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 213 prescription claims across 103 beneficiaries totaling $19,812 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 29 records totaling $1,006. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $477,338 to $1,250,553. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $8,296 and ending at $19,812. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$653K$1.3M2015 Medicare payment: $477,338 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $223,410 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $846,182 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $882,417 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $838,871 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,132,729 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,305,126 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,232,572 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $928,404 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,250,553 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154811,917$477,338
20164201,458$223,410
20179365,882$846,182
20189416,577$882,417
20197785,928$838,871
20207486,952$1,132,729
20216166,412$1,305,126
20226666,904$1,232,572
20235567,072$928,404
202450414,266$1,250,553

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$12K$24K2015 Drug cost: $8,296 (USD; Tot_Drug_Cst)2016 Drug cost: $5,026 (USD; Tot_Drug_Cst)2017 Drug cost: $14,099 (USD; Tot_Drug_Cst)2018 Drug cost: $23,756 (USD; Tot_Drug_Cst)2019 Drug cost: $23,504 (USD; Tot_Drug_Cst)2020 Drug cost: $13,640 (USD; Tot_Drug_Cst)2021 Drug cost: $10,399 (USD; Tot_Drug_Cst)2022 Drug cost: $8,812 (USD; Tot_Drug_Cst)2023 Drug cost: $22,520 (USD; Tot_Drug_Cst)2024 Drug cost: $19,812 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201569161$8,296
20163980$5,026
2017109255$14,099
2018178444$23,756
2019120313$23,504
2020114291$13,640
2021109229$10,399
2022104217$8,812
202388185$22,520
2024103213$19,812

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg114738$650
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more361486$96
67028Injection of drug into eye214644$94
92134Imaging of retina435960$30
92250Photography of the retina7494$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate922,184$2,120
OfloxacinOfloxacin681,874$688

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.29$1,006Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew J. Dykhuizen, M.D.?

Tedicare shows public-source Medicare data for Matthew J. Dykhuizen, M.D. (NPI 1609004308), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew J. Dykhuizen, M.D. have ACO affiliation data?

Matthew J. Dykhuizen, M.D. is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Matthew J. Dykhuizen, M.D.?

Matthew J. Dykhuizen, M.D. is linked to TRI-STATE CENTERS FOR SIGHT, INC. (billing NPI 1467520296) in the available physician profile data.

Does Matthew J. Dykhuizen, M.D. have Open Payments data?

Matthew J. Dykhuizen, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.